COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF (CAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04239534
Recruitment Status : Suspended (Start-up and enrolling activities have been temporatily suspended due to the COVID-19 pandemic.)
First Posted : January 27, 2020
Last Update Posted : June 4, 2020
Information provided by (Responsible Party):
AtriCure, Inc.

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : November 2026